Agranulocytosis and Aseptic Meningitis Induced by Sulfamethoxazole-Trimethoprim

Alison A Bunnell1, Kimberly D P Hammer1,2,3, Regan R Miller1

  • 1Fargo Veterans Affairs Health Care System, North Dakota.

Abstract

Insights

Sulfamethoxazole-trimethoprim can cause rare adverse effects. An immunocompetent patient developed agranulocytosis and aseptic meningitis after taking this antibiotic.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neurology

Background:

  • Sulfamethoxazole-trimethoprim is a commonly prescribed antibiotic.
  • It carries a risk of rare but severe adverse effects.
  • This case focuses on an immunocompetent individual.

Observation:

  • A healthy 39-year-old male presented with epididymo-orchitis.
  • He was treated with sulfamethoxazole-trimethoprim.
  • He later developed fever, headache, and body aches, leading to hospitalization.

Findings:

  • The patient was diagnosed with acute agranulocytosis.
  • Aseptic meningitis was also identified as a complication.
  • Both conditions were secondary to sulfamethoxazole-trimethoprim use.

Implications:

  • This case underscores the potential for severe hematologic and neurologic adverse events with sulfamethoxazole-trimethoprim.
  • It highlights the importance of recognizing these rare complications, even in immunocompetent patients.
  • Clinicians should maintain a high index of suspicion for drug-induced conditions when evaluating patients with these symptoms.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.9K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
49
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
68
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
465